During a live event, Matthew Lunning, DO, interpreted long-term outcomes of the ZUMA-7 and TRANSFORM trials.
For patients with Waldenström macroglobulinemia (WM), transitioning from ibrutinib (Imbruvica) to zanubrutinib (Brukinsa) may offer comparable clinical outcomes, as suggested by interim data from a ...
The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
The devastating consequences of mucopolysaccharidosis II (MPS II), also called Hunter syndrome, may soon become preventable ...
Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...
EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...
EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...
U.S. Supreme Court Justices Clarence Thomas and Samuel Alito appeared to side with the state of Alabama during the execution case of Joseph Clifton Smith on Wednesday. The Supreme Court heard two ...
Cardiovascular diseases, including cardiometabolic diseases and related conditions, are the leading causes of death and disability worldwide. 1 Despite advances in pharmacological treatments, ...
1 Graduate School of Design, National Yunlin University of Science and Technology, Douliu, Taiwan 2 Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital Yunlin ...
Forbes contributors publish independent expert analyses and insights. I write about 21st century leadership, Agile, innovation & narrative. Why do firms exist? In 1991, British economist Ronald Coase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback